1. Adjuvant Breast Cancer Therapy with …

    INDICATIONS: Adjuvant Breast Cancer Herceptin is indicated for adjuvant treatment of HER2-overexpressing node-positive or node-negative ...

  2. Adjuvant Paclitaxel and Trastuzumab for …

    Clinical Trials - clinicaltrials.gov The purpose of this study is to find out what effect the postoperative combination of therapies: trastuzumab (herceptin) an...

  3. Protocol - ResearchGate

    Supplement to: Adjuvant paclitaxel and trastuzumab for node-negative HER2+ breast cancer. Contents . Final Protocol: 01-18-14 page 3 …

  4. Abstract S1-04: A phase II study of adjuvant …

    Abstract S1-04: A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC)

  5. Optimizing Treatment for Small, Lymph …

    Optimizing Treatment for Small, Lymph Node–Negative, HER2-Overexpressing Breast Cancers. ... Adjuvant paclitaxel and trastuzumab for node-negative, ...

  6. Small HER2-positive, node-negative breast …

    Small HER2-positive, node-negative ... the benefit of adjuvant trastuzumab in HER2 ... will receive paclitaxel and trastuzumab for 12 weeks ...

  7. Adjuvant paclitaxel and trastuzumab for node-negative ...

    Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med 2015 Jan 8;372(2):134-41 PMID:25564897 ...

  8. 2015 NEJM APT Adjuvant paclitaxel and trastuzumab …

    The n e w e ng l a n d j o u r na l of m e dic i n e Original Article Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer Sara?M ...

  9. Paclitaxel, Trastuzumab New Standard of …

    Paclitaxel, Trastuzumab New Standard of ... node-negative HER2-positive breast cancers were ... results from the uncontrolled Adjuvant Paclitaxel and Trastuzumab ...

  10. Adjuvant Paclitaxel and Trastuzumab for …

    Clinical Trials - clinicaltrials.gov The purpose of this study is to find out what effect the postoperative combination of therapies: trastuzumab (herceptin) an...

  11. Evolving Standards in HER2-Targeted …

    Tolaney SM, Barry WT, Dang CT, et al. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med. 2015;372:134 ...

  12. Herceptin Plus Taxol Reduces Recurrence …

    Herceptin Plus Taxol Reduces Recurrence ... (chemical name: paclitaxel) ... Read the abstract of "Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2 ...

  13. Adjuvant paclitaxel and trastuzumab for …

    BACKGROUND: No single standard treatment exists for patients with small, node-negative, human epidermal growth factor receptor type 2 (HER2…

  14. Treatment of Lymph Node–Negative, Early …

    ... who have pT1ab node-negative HER2 ... efficacy of adjuvant paclitaxel and trastuzumab in ... paclitaxel and trastuzumab for node-negative, ...

  15. Adjuvant Paclitaxel and Trastuzumab for …

    Official Full-Text Paper (PDF): Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

  16. Adjuvant Paclitaxel and Trastuzumab for …

    Official Full-Text Paper (PDF): Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

  17. Medline ® Abstract for Reference 8 of …

    Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

  18. Adjuvant Paclitaxel and Trastuzumab for …

    The purpose of this study is to find out what effect the postoperative combination of therapies: trastuzumab (herceptin) and paclitaxel (taxol) will have on breast ...

  19. The short-term safety of adjuvant paclitaxel plus ...

    early-stage, HER2-amplified and node-negative BC. Key words: breast cancer, HER2 positive, node negative, ... Safety of adjuvant paclitaxel plus trastuzumab 323

  20. Adjuvant paclitaxel and trastuzumab for …

    TY - JOUR. T1 - Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. AU - Tolaney,Sara M. AU - Barry,William T. AU - Dang,Chau T.

    1. Leave Your Inquiry